• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX15; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX15; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX15RW30
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Information (3190)
Date of Event 06/10/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.Pma/510(k)- k130520.The actual device has been returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record and product release decision control sheet of the involved product code/lot number combination was conducted with no findings.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.Exemption number e2015022.
 
Event or Problem Description
The user facility reported that the involved oxygenator cx*fx15rw30 was leaking during use; it was found during priming; blood lost was not related to the reported event.The actual sample was changed out.The event occurred pre-treatment; there was no patient involvement, the patient outcome and patient condition was not available.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to update and to provide the completed investigation results.The actual device was received for evaluation.Visual inspection revealed that the three-way valve attached by the customer to the venous blood inlet port on the reservoir had been broken.On the remainders of the actual sample, there was not any other obvious anomaly, such as a break, in the appearance.The broken three-way stopcock was replaced with a factory-retained yellow cap.The actual sample was, then, built into a circuit with tubes and saline solution was circulated in it.No leak was observed.Subsequently, the blood phase of the oxygenator module was filled with saline solution.With the blood outlet port side clamped, an air pressure of 2kgf/cm2 was applied to the blood phase from the blood inlet port.No leak was observed.Then, the water phase of the heat exchanger housed in the oxygenator module was filled with water.With the water outlet port side clamped, an air pressure of 3kgf/cm2 was applied to the water phase from the water inlet port.No leak was observed.Colored water was used for better visibility of the behavior of the solution.Based on the provided information and investigation results, there is no definitive evidence that this event was related to a device defect or malfunction.The investigation results verified the returned sample was of the normal product.The exact cause of the reported event cannot be definitively determined based on the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX15
Common Device Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key8763914
Report Number9681834-2019-00113
Device Sequence Number1489668
Product Code DTZ
UDI-Device Identifier04987350701169
UDI-Public04987350701169
Combination Product (Y/N)N
Initial Reporter CountryHK
PMA/510(K) Number
K071494
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2021
Device Catalogue NumberCX*FX15RW30
Device Lot Number180425C
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/27/2019
Initial Date Received by Manufacturer 06/12/2019
Supplement Date Received by Manufacturer06/27/2019
Initial Report FDA Received Date07/05/2019
Supplement Report FDA Received Date07/17/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age3 YR
-
-